| Patents for C07K 16 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies (149,320) |
|---|
| 04/14/2011 | CA2774734A1 A cytolytic rtx-toxin from gallibacterium anatis |
| 04/13/2011 | EP2309264A1 Device for detection of influenza virus |
| 04/13/2011 | EP2308996A1 Therapeutic and diagnostic applications based on the role of the CXCR-4 and SDF-1 genes in tumourigenesis |
| 04/13/2011 | EP2308982A1 Methods of constructing display libraries of genetic packages for members of a diverse family of peptides |
| 04/13/2011 | EP2308975A1 Antibody molecules having specificity for human tumor necrosis factor alpha, and use thereof |
| 04/13/2011 | EP2308974A2 Anthozoa derived chromo/fluoroproteins and methods for using the same |
| 04/13/2011 | EP2308973A1 Method to screen phage display libraries with different ligands |
| 04/13/2011 | EP2308968A1 Compositions and methods for the treatment of immune related diseases |
| 04/13/2011 | EP2308899A1 Antibody complex, antigen detection method, and method for production of antibody complex |
| 04/13/2011 | EP2308898A1 Internalizing anti-CD74 antibodies and methods of use |
| 04/13/2011 | EP2308897A1 Chimeric antibodies specific for CD151 and use thereof in the treatment of cancer |
| 04/13/2011 | EP2308896A1 Polypeptides for binding to the "receptor for advanced glycation endproducts" as well as compositions and methods involving the same |
| 04/13/2011 | EP2308895A1 Anti-HSV antibody |
| 04/13/2011 | EP2308894A2 Humanized anti-NGF antibodies |
| 04/13/2011 | EP2308888A1 Anti-IL-6 antibodies, compositions, methods and uses |
| 04/13/2011 | EP2308507A2 Methods of diagnosing and treating pre-eclampsia or eclampsia |
| 04/13/2011 | EP2307459A2 Notch1 receptor binding agents and methods of use thereof |
| 04/13/2011 | EP2307458A2 Humanization of rabbit antibodies using a universal antibody framework |
| 04/13/2011 | EP2307457A2 Stable and soluble antibodies inhibiting tnf |
| 04/13/2011 | EP2307456A2 Ang-2 inhibition to treat multiple sclerosis |
| 04/13/2011 | EP2307455A1 Solubility optimization of immunobinders |
| 04/13/2011 | EP2307454A2 Stable and soluble antibodies inhibiting vegf |
| 04/13/2011 | EP2307453A1 Method of providing immunoglobulin secreting b lymphocytes and human antibodies |
| 04/13/2011 | EP2307452A1 Method for optimizing proteins having the folding pattern of immunoglobulin |
| 04/13/2011 | EP2307451A1 Biomarkers for rheumatoid arthritis |
| 04/13/2011 | EP2307052A2 Anti-beta-2-microglobulin agents and the use thereof |
| 04/13/2011 | EP2307051A2 Notch-binding agents and antagonists and methods of use thereof |
| 04/13/2011 | EP2307050A1 Use of an efficacy marker for optimizing therapeutic efficacy of an anti-human pd-1 antibody on cancers |
| 04/13/2011 | EP1928999B1 Methods of producing stable b-lymphocytes |
| 04/13/2011 | EP1883698B1 Monoclonal antibodies and single chain antibody fragments against cell-surface prostate specific membrane antigen |
| 04/13/2011 | EP1874818B1 Tgf beta 1 specific antibodies |
| 04/13/2011 | EP1749210B1 Isolation of allergen-specific immunoglobulin genes from human b-cells from atopy sufferers |
| 04/13/2011 | EP1558640B1 Trimeric binding proteins for trimeric cytokines |
| 04/13/2011 | EP1458749B1 Bone polypeptide-1 |
| 04/13/2011 | EP1440086B1 Infectious salmon anaemia virus vaccine |
| 04/13/2011 | EP1237584B1 Receptor binding conjugates |
| 04/13/2011 | EP0889735B1 Immunological methods for the treatment of gastrointestinal cancer |
| 04/13/2011 | CN1910456B Marker for neuromyelitis optica |
| 04/13/2011 | CN1910293B Detection of mutations in a gene associated with resistance to viral infection, OASI |
| 04/13/2011 | CN1898383B Unsaturated fatty acid synthase gene originating in marchantiales plant and utilization of the same |
| 04/13/2011 | CN1763097B Polypeptide variants with altered effector function |
| 04/13/2011 | CN1759123B Uses of IL-23 agonists and antagonists, related reagents |
| 04/13/2011 | CN1649902B Internalizing anti-CD74 antibodies and methods of use |
| 04/13/2011 | CN102016064A Nucleotide triphosphate with an electroactive label conjugated to the gamma phosphate |
| 04/13/2011 | CN102016026A Nucleic acid containing chimeric gene derived from hepatitis type-C virus |
| 04/13/2011 | CN102015771A Multifunctional linker protein containing an antibody against hemagglutinin, a conserved influenza antigen and an immunostimulating carrier binding domain |
| 04/13/2011 | CN102015770A Immunoglobulin compositions and methods of producing same |
| 04/13/2011 | CN102015769A Improved anti-TRKB antibodies |
| 04/13/2011 | CN102015768A Use of a radioactively labelled molecule specifically binding to ED-B fibronectin in a method of hodgkin lymphoma |
| 04/13/2011 | CN102015767A Cross-neutralizing human monoclonal antibodies to SARS-CoV and methods of use thereof |
| 04/13/2011 | CN102015766A Compositions and methods for the therapy and diagnosis of cytomegalovirus |
| 04/13/2011 | CN102015765A Binding protein and epitope-blocking ELISA for the universal detection of H5-subtype influenza viruses |
| 04/13/2011 | CN102015755A Vaccines and vaccine components for inhibition of microbial cells |
| 04/13/2011 | CN102015754A Klebsiella antigens |
| 04/13/2011 | CN102014964A Compositions and methods for the treatment of tumor of hematopoietic origin |
| 04/13/2011 | CN102014958A Inhibitors of GM-CSF and IL-17 for therapy |
| 04/13/2011 | CN102014948A Modulation of adenoviral tropism |
| 04/13/2011 | CN102012433A Avian influenza virus H9 subtype positive blood serum and negative blood serum standard substances and preparation methods thereof |
| 04/13/2011 | CN102012429A Aeromonas hydrophila aerolysin Dot-ELISA detection method |
| 04/13/2011 | CN102010870A High-expression streptolysin O (SLO) gene as well as secreting expression vector and application thereof |
| 04/13/2011 | CN102010472A Anti-D-dimer monoclonal antibody and application thereof |
| 04/13/2011 | CN102010471A Interleukin-10 antibodies |
| 04/13/2011 | CN102010470A Collagen type IV (CIV) monoclonal antibody and application thereof |
| 04/13/2011 | CN102010469A Hyaluronic acid resistance monoclonal antibody and application thereof |
| 04/13/2011 | CN102010468A Toxoplasma circulating antigen double antibody sandwich ELISA (Enzyme-Linked Immuno Sorbent Assay) detection method |
| 04/13/2011 | CN101275147B Expression vector and fused protein of human differential initiator 3 and preparation thereof |
| 04/13/2011 | CN101058609B Human antibody and expression thereof |
| 04/12/2011 | US7923543 Nucleic acid and corresponding protein entitled 162P1E6 useful in treatment and detection of cancer |
| 04/12/2011 | US7923539 IL-21 antagonists |
| 04/12/2011 | US7923534 Isolated tumor rejection antigen precursor proteins MAGE-2 and MAGE-3 |
| 04/12/2011 | US7923250 Transfection with nucleic acid; insertion |
| 04/12/2011 | US7923221 Methods of making antibody heavy and light chains having specificity for a desired antigen |
| 04/12/2011 | US7923212 Antibodies to cytokine receptor zalpha11 |
| 04/12/2011 | US7923208 Using presence of variation in Zcytor16 gene sequences as evaluative tool in diagnosis of cell proliferative disorders |
| 04/12/2011 | US7923018 Vaccine |
| 04/12/2011 | US7923012 Immunizing an animal using polypeptide; amino acid sequences; controlling phosphate, vitamin D metabolism |
| 04/12/2011 | US7923011 Antibodies to lymphotoxin-alpha |
| 04/12/2011 | US7923010 Methods and materials for treating autoimmune diseases and conditions |
| 04/12/2011 | US7923009 Medicinal agent and method for curing prostate diseases |
| 04/12/2011 | US7923008 monoclonal antibodies; treat bone diseases characterized by changes in bone resorption, such as osteoporosis, hypercalcemia, bone loss due to arthritis metastasis, immobilization or periodontal disease, Paget's disease; denosumab |
| 04/12/2011 | CA2456172C Kidney-specific urate transporter and uses thereof |
| 04/12/2011 | CA2388363C Dna polymerase lambda and uses thereof |
| 04/12/2011 | CA2354153C Compounds and methods for modulating activation of nf-.kappa.b |
| 04/12/2011 | CA2311409C Treatment with anti-erbb2 antibodies |
| 04/12/2011 | CA1341611C Interleukin-1 receptors |
| 04/07/2011 | WO2011041790A1 Piscine reovirus diagnostic compositions |
| 04/07/2011 | WO2011041789A1 Piscine reovirus immunogenic compositions |
| 04/07/2011 | WO2011041584A2 Methods for modulation of autophagy through the modulation of autophagy-enhancing gene products |
| 04/07/2011 | WO2011041391A1 Influenza hemagglutinin antibodies, compositions, and related methods |
| 04/07/2011 | WO2011041350A2 Xenotropic mulv-related virus (xmrv) compositions and methods of use |
| 04/07/2011 | WO2011041336A2 Methods of treating cancer using notch antagonists |
| 04/07/2011 | WO2011041093A1 Anti-vascular endothelial growth factor receptor-2 chimeric antigen receptors and use of same for the treatment of cancer |
| 04/07/2011 | WO2011040972A1 Anti-fibroblast activation protein antibodies and methods and uses thereof |
| 04/07/2011 | WO2011040668A1 Antibodies specifically binding to the epidermal growth factor receptor |
| 04/07/2011 | WO2011040565A1 Anti-podoplanin antibody, and pharmaceutical composition containing anti-podoplanin antibody |
| 04/07/2011 | WO2011040500A1 Peptide inhibiting differentiation of hematopoietic stem cells or hematopoietic precursor cells and use of same |
| 04/07/2011 | WO2011040469A1 Novel pacemaker cell |
| 04/07/2011 | WO2011040429A1 Monoclonal antibody against human hig-1 polypeptide |
| 04/07/2011 | WO2011040285A1 Dna construct, and process for production of recombinant cho cell using same |
| 04/07/2011 | WO2011040133A1 Human serum amyloid-a3 antibody and use thereof |